TTD_Target_ID Target_Name TTD_Drug_ID Drug_Name Drug_Highest_Status Drug_PubchemID Molecular_Formula Molecular_Weight Canonical_SMILES Activity Binder_Type T97747 HUMAN C-C chemokine receptor 5 B0CTW9 4-[4-[[(3S)-1-Butyl-3-[(S)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 23577461 C33H44ClN3O6 614.2 CCCCN1C(=O)[C@@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@H](C5CCCCC5)O.Cl IC50 = 51000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0GX9B 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-hexyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56678577 C36H51ClN4O5 655.3 CCCCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)NC)[C@@H](C5CCCCC5)O.Cl IC50 = 110000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0H2XD 2,2'-Bipyridine Investigative 1474 C10H8N2 156.18 C1=CC=NC(=C1)C2=CC=CC=N2 IC50 = 79432.82 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0JZ8T N-(4-((E)-3-Oxo-5-(3,4-dihydroxyphenyl)-4-pentenyl)phenyl)-2-thienylacetamide Investigative 129908557 C23H21NO4S 407.5 C1=CSC(=C1)CC(=O)NC2=CC=C(C=C2)CCC(=O)/C=C/C3=CC(=C(C=C3)O)O EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0QC1M (3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-9-[(4-phenoxyphenyl)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride Investigative 23577403 C32H44ClN3O4 570.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=CC=C4)[C@@H](C5CCCCC5)O.Cl IC50 = 53000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0UFC5 N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]benzamide Investigative 73351054 C32H41N3O2 499.7 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC(C)C)NC(=O)C4=CC=CC=C4 IC50 = 138000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0V1OX N-[2-Ethoxy-5-[1-[(4-nitrophenyl)methyl]piperidin-4-yl]phenyl]pyrazine-2-carboxamide Investigative 73346461 C25H27N5O4 461.5 CCOC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)C4=NC=CN=C4 IC50 = 61000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0VWI3 N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 73352529 C30H39N5O2 501.7 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC(C)C)NC(=O)C4=NC=CN=C4 IC50 = 61000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B0W5PJ Methyl 4-[[4-[4-propan-2-yloxy-3-(pyrazine-2-carbonylamino)phenyl]piperazin-1-yl]methyl]benzenesulfonate Investigative 90656336 C26H31N5O5S 525.6 CC(C)OC1=C(C=C(C=C1)N2CCN(CC2)CC3=CC=C(C=C3)S(=O)(=O)OC)NC(=O)C4=NC=CN=C4 IC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B15DIM 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-(3-hydroxybutyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56657985 C34H47ClN4O6 643.2 CC(CCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)NC)[C@@H](C5CCCCC5)O)O.Cl IC50 = 180000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B15UGR 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-ethyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56661525 C32H43ClN4O5 599.2 CCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)NC)[C@@H](C5CCCCC5)O.Cl IC50 = 178000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B1J7FU 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-2,5-dioxo-1-pentyl-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56681916 C35H49ClN4O5 641.2 CCCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)NC)[C@@H](C5CCCCC5)O.Cl IC50 = 68000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B27GQW 4-Cyano-N-[[8-[[(4-cyanobenzoyl)amino]methyl]-5,7-dimethyl-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]benzamide;chloride Investigative 122185628 C28H26ClN5O2 500 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)C#N)C)CNC(=O)C4=CC=C(C=C4)C#N.[Cl-] IC50 = 101200 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B2QE3U N-(4-((E)-3-Oxo-5-(3,4-dihydroxyphenyl)-4-pentenyl)phenyl)cyclohexanecarboxamide Investigative 129908214 C24H27NO4 393.5 C1CCC(CC1)C(=O)NC2=CC=C(C=C2)CCC(=O)/C=C/C3=CC(=C(C=C3)O)O EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B3L7YM N-[5-[1-[(4-Nitrophenyl)methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 73349499 C26H29N5O4 475.5 CC(C)OC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)C4=NC=CN=C4 IC50 = 65700 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B3UN8Z 5-[[4-(4-Benzyl-1H-pyrazol-5-yl)-1-piperidyl]methyl]-2-methoxy-pyrimidine Investigative 56754672 C21H25N5O 363.5 COC1=NC=C(C=N1)CN2CCC(CC2)C3=C(C=NN3)CC4=CC=CC=C4 IC50 = 70000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B4ZHX5 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-methyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56657983 C31H41ClN4O5 585.1 CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4C)[C@@H](C5CCCCC5)O.Cl IC50 = 59000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B4ZUM6 N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-ethoxyphenyl]pyrazine-2-carboxamide Investigative 73351060 C29H37N5O2 487.6 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OCC)NC(=O)C4=NC=CN=C4 IC50 = 51800 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B5GJ2B 4-Fluoro-N-[[8-[[(4-fluorobenzoyl)amino]methyl]-5,7-dimethyl-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]benzamide;chloride Investigative 122185626 C26H26ClF2N3O2 486 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)F)C)CNC(=O)C4=CC=C(C=C4)F.[Cl-] IC50 = 80900 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B5PZ1F N-[5-[1-[(4-Acetamidophenyl)methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]benzamide Investigative 73352528 C30H35N3O3 485.6 CC(C)OC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)NC(=O)C)NC(=O)C4=CC=CC=C4 IC50 = 92200 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B6BZ1Q N-(4-((E)-3-Oxo-5-(3,4-diacetoxyphenyl)-4-pentenyl)phenyl)benzamide Investigative 129908240 C28H25NO6 471.5 CC(=O)OC1=C(C=C(C=C1)/C=C/C(=O)CCC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3)OC(=O)C EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B6GH9U Fuscinarin Investigative 10445499 C14H16O5 264.27 CC1C2=C(C(=C3C(=C2C(=O)O1)CCC(O3)(C)C)O)O IC50 = 80000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B72XPF Benzyl ethyl{1-[3-phenyl-5-(phenylsulfonyl)heptyl]piperidin-4-yl}carbamate Investigative 483350 C34H44N2O4S 576.8 CCC(CC(CCN1CCC(CC1)N(CC)C(=O)OCC2=CC=CC=C2)C3=CC=CC=C3)S(=O)(=O)C4=CC=CC=C4 IC50 = 88000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B7EF5H 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-(2-methoxyethyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 23577327 C33H45ClN4O6 629.2 CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CCOC)[C@@H](C5CCCCC5)O.Cl IC50 = 98000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B7L2ZM N-(4-((E)-3-Oxo-5-(3,4-diacetoxyphenyl)-4-pentenyl)phenyl)-2-thienylacetamide Investigative 129908112 C27H25NO6S 491.6 CC(=O)OC1=C(C=C(C=C1)/C=C/C(=O)CCC2=CC=C(C=C2)NC(=O)CC3=CC=CS3)OC(=O)C EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B7WQ3C [(1R,2S,3S,5R,6R,8S,10E,12R,13S,15R,16S,17R,18S)-18-Benzyl-6-hydroxy-6,8,15,16-tetramethyl-7,20-dioxo-4,14-dioxa-19-azapentacyclo[10.8.0.01,17.03,5.013,15]icos-10-en-2-yl] acetate Investigative 44559501 C30H37NO7 523.6 C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2([C@@H]([C@H]5[C@@H](O5)[C@@](C1=O)(C)O)OC(=O)C)C(=O)N[C@H]4CC6=CC=CC=C6)C)C IC50 = 60000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B8BX0Q N-[5-[1-[(4-Aminophenyl)methyl]piperidin-4-yl]-2-ethoxyphenyl]benzamide Investigative 73347961 C27H31N3O2 429.6 CCOC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)N)NC(=O)C4=CC=CC=C4 IC50 = 63000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B8OG4D 4-[4-[[(3R)-1-Butyl-3-[(R)-cyclobutyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56661523 C31H40ClN3O6 586.1 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCC5)O.Cl IC50 = 66000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B91PLB 1,10-Phenanthroline Investigative 1318 C12H8N2 180.2 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 IC50 = 50118.72 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B9KB3T (3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-9-[[4-(4-methoxyphenoxy)phenyl]methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride Investigative 23577377 C33H46ClN3O5 600.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)OC)[C@@H](C5CCCCC5)O.Cl IC50 = 91000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B9L3XU Abametapir Investigative 15664 C12H12N2 184.24 CC1=CN=C(C=C1)C2=NC=C(C=C2)C IC50 = 199526.23 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B9S0TK Neocuproine Investigative 65237 C14H12N2 208.26 CC1=NC2=C(C=C1)C=CC3=C2N=C(C=C3)C EC50 = 63095.73 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 B9UE7V N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-methoxyphenyl]benzamide Investigative 73351055 C30H37N3O2 471.6 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC)NC(=O)C4=CC=CC=C4 IC50 = 90000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BA8OE5 N-[[5,7-Dimethyl-8-[[(4-nitrobenzoyl)amino]methyl]-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]-4-nitrobenzamide;chloride Investigative 122185624 C26H26ClN5O6 540 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C)CNC(=O)C4=CC=C(C=C4)[N+](=O)[O-].[Cl-] IC50 = 67700 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BBNO01 4-[4-[[(3R)-1-Butyl-3-[(R)-cyclopropyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56661521 C30H38ClN3O6 572.1 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CC5)O.Cl IC50 = 81000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BC1HB9 N-[5-[1-[(4-Acetamidophenyl)methyl]piperidin-4-yl]-2-ethoxyphenyl]benzamide Investigative 73346460 C29H33N3O3 471.6 CCOC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)NC(=O)C)NC(=O)C4=CC=CC=C4 IC50 = 115000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BDA91Z N-[5-[4-[(4-Cyanophenyl)methyl]piperazin-1-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 90656331 C26H28N6O2 456.5 CC(C)OC1=C(C=C(C=C1)N2CCN(CC2)CC3=CC=C(C=C3)C#N)NC(=O)C4=NC=CN=C4 IC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BDT4S3 N-[4-[5-(3,4-Dihydroxyphenyl)-3-oxo-pentyl]phenyl]-2-(2-thienyl)acetamide Investigative 129908560 C23H23NO4S 409.5 C1=CSC(=C1)CC(=O)NC2=CC=C(C=C2)CCC(=O)CCC3=CC(=C(C=C3)O)O EC50 = 55370 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BE3B4A N-(4-((E)-3-Oxo-5-(3,4-dihydroxyphenyl)-4-pentenyl)phenyl)benzamide Investigative 129908179 C24H21NO4 387.4 C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CCC(=O)/C=C/C3=CC(=C(C=C3)O)O EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BE4QT9 3,5-Bis[(Z)-dec-1-enyl]-2,4,6-trimethylpyridine Investigative 62707285 C28H47N 397.7 CCCCCCCC/C=C\\C1=C(C(=C(N=C1C)C)/C=C\\CCCCCCCC)C IC50 ~ 100000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BF78QI N-[5-[1-[(4-Acetamidophenyl)methyl]piperidin-4-yl]-2-methoxyphenyl]benzamide Investigative 73346454 C28H31N3O3 457.6 CC(=O)NC1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC)NC(=O)C4=CC=CC=C4 IC50 = 70800 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BFS14W N-[2-Methoxy-5-[1-[(4-nitrophenyl)methyl]piperidin-4-yl]phenyl]pyrazine-2-carboxamide Investigative 73355552 C24H25N5O4 447.5 COC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)C4=NC=CN=C4 IC50 = 73000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BFZ3N9 N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-ethoxyphenyl]benzamide Investigative 73357100 C31H39N3O2 485.7 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OCC)NC(=O)C4=CC=CC=C4 IC50 = 64000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BGF39E N-[5-[1-[(4-Acetamidophenyl)methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 73349500 C28H33N5O3 487.6 CC(C)OC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)NC(=O)C)NC(=O)C4=NC=CN=C4 IC50 = 88100 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BHU17J 1,10-Phenanthroline-2,9-dicarbaldehyde Investigative 602123 C14H8N2O2 236.22 C1=CC2=C(C3=C1C=CC(=N3)C=O)N=C(C=C2)C=O IC50 = 125892.54 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BJMN10 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-heptyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]-N-methylbenzamide;hydrochloride Investigative 56664938 C37H53ClN4O5 669.3 CCCCCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)NC)[C@@H](C5CCCCC5)O.Cl IC50 = 190000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BKPC35 4-[4-[[(3R)-1-Butyl-3-[(S)-hydroxy-(4-hydroxycyclohexyl)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56678573 C33H44ClN3O7 630.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@H](C5CCC(CC5)O)O.Cl IC50 = 129000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BLZP61 2,9-Bis(bromomethyl)-1,10-phenanthroline Investigative 353741 C14H10Br2N2 366.05 C1=CC2=C(C3=C1C=CC(=N3)CBr)N=C(C=C2)CBr IC50 = 199526.23 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BM3H8J 1-Cyclohexyl-4-[(2-fluorophenyl)-[1-[(4-fluorophenyl)methyl]tetrazol-5-yl]methyl]piperazine Investigative 3209888 C25H30F2N6 452.5 C1CCC(CC1)N2CCN(CC2)C(C3=CC=CC=C3F)C4=NN=NN4CC5=CC=C(C=C5)F IC50 = 79400 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BMDA05 (3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-9-[[4-(4-hydroxyphenoxy)phenyl]methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride Investigative 23577369 C32H44ClN3O5 586.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)O)[C@@H](C5CCCCC5)O.Cl IC50 = 68000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BMQ7L9 N-[5-[1-[(4-Aminophenyl)methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 73355549 C26H31N5O2 445.6 CC(C)OC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)N)NC(=O)C4=NC=CN=C4 IC50 = 77800 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BMWC42 3,5-Bis[(Z)-dec-1-enyl]-2-(3-methoxypropyl)-4,6-dimethylpyridine Investigative 62707286 C31H53NO 455.8 CCCCCCCC/C=C\\C1=C(C(=C(N=C1C)CCCOC)/C=C\\CCCCCCCC)C IC50 ~ 100000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BN03JB 4-Methyl-1,10-phenanthroline Investigative 93149 C13H10N2 194.23 CC1=C2C=CC3=C(C2=NC=C1)N=CC=C3 IC50 = 63095.73 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BN9O0P 4-[4-[[(3R)-1-Butyl-3-[(S)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 53324597 C33H44ClN3O6 614.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@H](C5CCCCC5)O.Cl IC50 = 182000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BO3FG4 N-[5-[1-[(4-Aminophenyl)methyl]piperidin-4-yl]-2-propan-2-yloxyphenyl]benzamide Investigative 73354018 C28H33N3O2 443.6 CC(C)OC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)N)NC(=O)C4=CC=CC=C4 IC50 = 66200 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BO3YD8 N-[5-[4-[(3-Nitrophenyl)methyl]piperazin-1-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 90656327 C25H28N6O4 476.5 CC(C)OC1=C(C=C(C=C1)N2CCN(CC2)CC3=CC(=CC=C3)[N+](=O)[O-])NC(=O)C4=NC=CN=C4 IC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BQ7N3J N-[[5,7-Dimethyl-8-[[[4-(trifluoromethyl)benzoyl]amino]methyl]-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]-4-(trifluoromethyl)benzamide;chloride Investigative 122185622 C28H26ClF6N3O2 586 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)C(F)(F)F)C)CNC(=O)C4=CC=C(C=C4)C(F)(F)F.[Cl-] IC50 = 121500 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BQS94X 4-[4-[[(3R)-1-Butyl-3-[(R)-hydroxy-(4-hydroxycyclohexyl)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56675255 C33H44ClN3O7 630.2 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCC(CC5)O)O.Cl IC50 = 140000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BR3SI2 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-2,5-dioxo-1-propyl-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 23577447 C32H42ClN3O6 600.1 CCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O.Cl IC50 = 112000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BR8M7U N-[5-[1-[(4-Acetamidophenyl)methyl]piperidin-4-yl]-2-methoxyphenyl]pyrazine-2-carboxamide Investigative 73352534 C26H29N5O3 459.5 CC(=O)NC1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC)NC(=O)C4=NC=CN=C4 IC50 = 59000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BRX49M 10-Methoxydihydrofuscin Investigative 10425374 C16H20O6 308.33 CC1C2=C(C(=C3C(=C2C(C(=O)O1)OC)CCC(O3)(C)C)O)O IC50 = 154000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BT5Q8P 4-[4-[[(3R)-3-[(R)-Cyclohexyl(hydroxy)methyl]-1-methyl-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56664934 C30H38ClN3O6 572.1 CN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O.Cl IC50 = 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BTEN79 N-[5-[4-[(3,5-Dinitrophenyl)methyl]piperazin-1-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 90656329 C25H27N7O6 521.5 CC(C)OC1=C(C=C(C=C1)N2CCN(CC2)CC3=CC(=CC(=C3)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C4=NC=CN=C4 IC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BU5WP6 N-[4-[(E)-5-(3,4-Dihydroxyphenyl)-3-oxo-pent-4-enyl]phenyl]-4-nitro-benzamide Investigative 129908213 C24H20N2O6 432.4 C1=CC(=CC=C1CCC(=O)/C=C/C2=CC(=C(C=C2)O)O)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-] EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BU67TD N-(4-((E)-3-Oxo-5-(3,4-dihydroxyphenyl)-4-pentenyl)phenyl)-p-methylbenzamide Investigative 129908215 C25H23NO4 401.5 CC1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CCC(=O)/C=C/C3=CC(=C(C=C3)O)O EC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BV42MK N-[5-[1-[[4-(Diethylamino)phenyl]methyl]piperidin-4-yl]-2-methoxyphenyl]pyrazine-2-carboxamide Investigative 73349506 C28H35N5O2 473.6 CCN(CC)C1=CC=C(C=C1)CN2CCC(CC2)C3=CC(=C(C=C3)OC)NC(=O)C4=NC=CN=C4 IC50 = 56000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BV9B4P 4-Amino-N-[[8-[[(4-aminobenzoyl)amino]methyl]-5,7-dimethyl-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]benzamide;chloride Investigative 122185630 C26H30ClN5O2 480 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)N)C)CNC(=O)C4=CC=C(C=C4)N.[Cl-] IC50 = 173900 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BX5D1N 4-[4-[[(3R)-1-Butyl-3-[(R)-hydroxy(oxan-4-yl)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride Investigative 56671868 C32H42ClN3O7 616.1 CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCOCC5)O.Cl IC50 = 120000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BXCE65 N-[5-[4-[(4-Fluorophenyl)methyl]piperazin-1-yl]-2-propan-2-yloxyphenyl]pyrazine-2-carboxamide Investigative 90656332 C25H28FN5O2 449.5 CC(C)OC1=C(C=C(C=C1)N2CCN(CC2)CC3=CC=C(C=C3)F)NC(=O)C4=NC=CN=C4 IC50 ~ 50000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BXOV76 4-Methoxy-N-[[8-[[(4-methoxybenzoyl)amino]methyl]-5,7-dimethyl-2,3-dihydro-1H-indolizin-4-ium-6-yl]methyl]benzamide;chloride Investigative 122185634 C28H32ClN3O4 510 CC1=C(C(=[N+]2CCCC2=C1CNC(=O)C3=CC=C(C=C3)OC)C)CNC(=O)C4=CC=C(C=C4)OC.[Cl-] IC50 = 69000 nM Poor binder T97747 HUMAN C-C chemokine receptor 5 BYG73M N-[5-[1-[(4-Aminophenyl)methyl]piperidin-4-yl]-2-methoxyphenyl]benzamide Investigative 73347956 C26H29N3O2 415.5 COC1=C(C=C(C=C1)C2CCN(CC2)CC3=CC=C(C=C3)N)NC(=O)C4=CC=CC=C4 IC50 = 77000 nM Poor binder